Daniel L. Spitz
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 6
-
- Endometrial and Cervical Cancer Treatments 3
- Co-authors
- Maurie M. Markman (1 shared paper)SHELDON A. WEINER (1 shared paper)James B. Hall (1 shared paper)Linda Van Le (1 shared paper)Linda F. Carson (1 shared paper)John Paul Micha (2 shared papers)Nicholas Simon Reed (2 shared papers)Johanna C. Bendell (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Gynecologic Oncology (3 papers)Annals of Oncology (2 papers)Blood (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Daniel L. Spitz
13 papers receiving 494 citations
Daniel L. Spitz's Hit Papers
Peers
Comparison fields: 5 of 44
- Reproductive Medicine 162
- Obstetrics and Gynecology 49
- Oncology 87
- Pulmonary and Respiratory Medicine 104
- Complementary and alternative medicine 19
Countries citing papers authored by Daniel L. Spitz
This map shows the geographic impact of Daniel L. Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Spitz more than expected).
Fields of papers citing papers by Daniel L. Spitz
This network shows the impact of papers produced by Daniel L. Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Spitz. The network helps show where Daniel L. Spitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel L. Spitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 181 | |
| 2 | Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study Hit paper breakdown → | 2024 | 99 |
| 3 | 2016 | 83 | |
| 4 | 2023 | 47 | |
| 5 | 2013 | 39 | |
| 6 | 2019 | 21 | |
| 7 | 2024 | 16 | |
| 8 | 2017 | 9 | |
| 9 | 1988 | 6 | |
| 10 | 2017 | 2 | |
| 11 | 2025 | 2 | |
| 12 | 2014 | 1 | |
| 13 | 2014 | 1 |
About Daniel L. Spitz
Daniel L. Spitz is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 13 papers that have together received 507 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (3 papers), Lung Cancer Treatments and Mutations (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Cancer Genomics and Diagnostics (1 paper), Immune Cell Function and Interaction (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Reproductive Medicine (162 citations), Obstetrics and Gynecology (49 citations), Oncology (87 citations), Pulmonary and Respiratory Medicine (104 citations) and Complementary and alternative medicine (19 citations). Daniel L. Spitz has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Maurie M. Markman, SHELDON A. WEINER, James B. Hall, Linda Van Le, Linda F. Carson, John Paul Micha, Nicholas Simon Reed, Johanna C. Bendell, Gordon J.S. Rustin and Linda Duska. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, Blood and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.